Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meiyu Fang

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Frontiers in Oncology|November 7, 2022
Case report: complete remission with crizotinib in <i>ROS1</i> fusion-positive sinonasal mucosal melanomaJun Cao, Yaner Yu, Yangkun Zhou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 10, 2015
Metformin enhances radiation response of ECa109 cells through activation of ATM and AMPKTingting Feng, Lei Li, Sunbin Ling, et al.
Clinical and Translational Medicine|January 6, 2025
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysisJie Dai, Tianxiao Xu, Lifeng Li, et al.
Endocrine-Related Cancer|January 23, 2024
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patientsXiangqian Zheng, Meiyu Fang, Yun Fan, et al.
Drug Design, Development and Therapy|December 1, 2025
Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid TumorsJian Fang, Ou Jiang, Wei Li, et al.
Eclinicalmedicine|August 18, 2025
Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I studyZhengfu Fan, Jin Wang, Dan Liu, et al.
Therapeutic Advances in Medical Oncology|June 17, 2024
Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II studyShukui Qin, Yusheng Wang, Jun Yao, et al.
JAMA Oncology|January 2, 2026
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype: The Phase 3 MELATORCH Randomized Clinical TrialXinan Sheng, Gang Huang, Meiyu Fang, et al.
Ebiomedicine|July 23, 2024
Profiling of viral load, antibody and inflammatory response of people with monkeypox during hospitalization: a prospective longitudinal cohort study in ChinaLi Guo, Rui Song, Qiao Zhang, et al.
Medcomm|November 24, 2025
Impaired Cellular Immunity and Cross-Reactive Humoral Responses to Mpox Virus in HIV-Infected Individuals Vaccinated with Vaccinia Virus Tiantan StrainQiao Zhang, Rui Song, Yu Huang, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|November 7, 2022
Case report: complete remission with crizotinib in <i>ROS1</i> fusion-positive sinonasal mucosal melanomaJun Cao, Yaner Yu, Yangkun Zhou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 10, 2015
Metformin enhances radiation response of ECa109 cells through activation of ATM and AMPKTingting Feng, Lei Li, Sunbin Ling, et al.
Clinical and Translational Medicine|January 6, 2025
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysisJie Dai, Tianxiao Xu, Lifeng Li, et al.
Endocrine-Related Cancer|January 23, 2024
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patientsXiangqian Zheng, Meiyu Fang, Yun Fan, et al.
Drug Design, Development and Therapy|December 1, 2025
Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid TumorsJian Fang, Ou Jiang, Wei Li, et al.
Eclinicalmedicine|August 18, 2025
Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I studyZhengfu Fan, Jin Wang, Dan Liu, et al.
Therapeutic Advances in Medical Oncology|June 17, 2024
Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II studyShukui Qin, Yusheng Wang, Jun Yao, et al.
JAMA Oncology|January 2, 2026
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype: The Phase 3 MELATORCH Randomized Clinical TrialXinan Sheng, Gang Huang, Meiyu Fang, et al.
Ebiomedicine|July 23, 2024
Profiling of viral load, antibody and inflammatory response of people with monkeypox during hospitalization: a prospective longitudinal cohort study in ChinaLi Guo, Rui Song, Qiao Zhang, et al.
Medcomm|November 24, 2025
Impaired Cellular Immunity and Cross-Reactive Humoral Responses to Mpox Virus in HIV-Infected Individuals Vaccinated with Vaccinia Virus Tiantan StrainQiao Zhang, Rui Song, Yu Huang, et al.
Pageof 8